A Type 1 diabetes intelligence desk with research, device, and care-planning materials.
Type1Cure original generated editorial image / Project-owned generated asset
Daily Briefing/September 4, 2026/3 min read

September 4, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

daily briefingtype 1 diabetestrialsdevice safetyresearch

The short version

The September 4, 2026 feed is strongest in three lanes: device safety, recruiting studies, and recent research records. Type1Cure treats safety and trial records as higher-priority signals because they can affect what a family may need to check, ask, or watch next.

This is not a medical recommendation. It is a source map and plain-English triage layer designed to help families decide what deserves a closer look with their care team.

Signals in the feed

  • Medtronic MiniMed, Inc.: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712; — Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypo...Source
  • Medtronic MiniMed, Inc.: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782; — Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypo...Source
  • Medtronic MiniMed, Inc.: MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLW — Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypo...Source
  • Medtronic MiniMed, Inc.: MiniMed Go App, Model: MMT-8600 (iOS), MMT-8601 (Android) — For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This cou...Source
  • Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes — RECRUITING. Interventions: Advanced artificial pancreas closed-loop technology. Locations: Jacksonville, Florida, United States | Orlando, Florida, United States. 50 children/adolescents (ages 6 to \<18yrs) with T1D in...Source
  • Medtronic MiniMed, Inc.: MiniMed 780G Insulin Pump, REF: MMT-1885, MMT-1886, MMT-1895, MMT-1896 — A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 foll...Source
  • Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes — RECRUITING. Interventions: Omnipod 5. Locations: Buffalo, New York, United States. This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Om...Source

How to use this briefing

Start with the evidence label. Official registry and regulator records are not the same thing as advice, but they are stronger source material than a repost, rumor, or promotional headline.

For trials, check eligibility, location, burden, intervention, and contact details at the original registry. For device safety, check exact product names, models, lot numbers, software versions, and manufacturer instructions.

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.